Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics

Wang, 2003, The relationship between diabetes and pancreatic cancer, Mol Cancer, 2, 4, 10.1186/1476-4598-2-4 Chari, 2008, Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer, Gastroenterology, 134, 95, 10.1053/j.gastro.2007.10.040 Permert, 1993, Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?, Am J Surg, 165, 61, 10.1016/S0002-9610(05)80405-2 Wang, 1997, Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines, Int J Pancreatol, 21, 157, 10.1007/BF02822387 Ding, 1998, Pancreatic cancer cells selectively stimulate islet β cells to secrete amylin, Gastroenterology, 114, 130, 10.1016/S0016-5085(98)70641-9 Valerio, 1999, Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: a low molecular weight factor possibly involved, Biochem Biophys Res Commun, 257, 622, 10.1006/bbrc.1999.0521 Gupta, 2006, New-onset diabetes and pancreatic cancer, Clin Gastroenterol Hepatol, 4, 1366, 10.1016/j.cgh.2006.06.024 Pannala, 2007, Very high prevalence of new-onset diabetes and impaired fasting glucose in pancreatic cancer—results of a case–control study, Gastroenterology, 132, A118 Fogar, 1994, Diabetes mellitus in pancreatic cancer follow-up, Anticancer Res, 14, 2827 Basso, 2004, Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes, Gut, 53, 1159, 10.1136/gut.2003.024471 Basso, 2002, Putative pancreatic cancer-associated diabetogenic factor: 2030MW peptide, Pancreas, 24, 8, 10.1097/00006676-200201000-00002 Basso, 2006, Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?, Clin Chim Acta, 372, 120, 10.1016/j.cca.2006.03.027 Zieske, 2006, A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies, J Exp Bot, 57, 1501, 10.1093/jxb/erj168 Ralhan, 2008, Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry, Mol Cell Proteomics, 7, 1162, 10.1074/mcp.M700500-MCP200 Pierce, 2008, Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases, Mol Cell Proteomics, 7, 853, 10.1074/mcp.M700251-MCP200 American Diabetes Association, 2007, Diagnosis and classification of diabetes mellitus, Diabetes Care, 30, S42, 10.2337/dc07-S042 Chari, 2005, Probability of pancreatic cancer following diabetes: a population-based study, Gastroenterology, 129, 504, 10.1016/j.gastro.2005.05.007 Roth, 2003, Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules, Trends Immunol, 24, 155, 10.1016/S1471-4906(03)00062-0 Cheng, 2008, Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein, J Exp Med, 205, 2235, 10.1084/jem.20080132 Sinha, 2008, Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells, J Immunol, 181, 4666, 10.4049/jimmunol.181.7.4666 Goyette, 2011, Inflammation-associated S100 proteins: new mechanisms that regulate function, Amino Acids, 41, 821, 10.1007/s00726-010-0528-0 Gebhardt, 2006, S100A8 and S100A9 in inflammation and cancer, Biochem Pharmacol, 72, 1622, 10.1016/j.bcp.2006.05.017 Salama, 2008, A review of the S100 proteins in cancer, Eur J Surg Oncol, 34, 357, 10.1016/j.ejso.2007.04.009 Sheikh, 2007, The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells, Proteomics, 7, 1929, 10.1002/pmic.200700072 Ichikawa, 2011, S100A8/A9 activate key genes and pathways in colon tumor progression, Mol Cancer Res, 9, 133, 10.1158/1541-7786.MCR-10-0394 Donato, 2001, S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles, Int J Biochem Cell Biol, 33, 637, 10.1016/S1357-2725(01)00046-2 Heizmann, 2002, S100 proteins: structure, functions and pathology, Front Biosci, 7, d1356, 10.2741/heizmann Marenholz, 2004, S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature), Biochem Biophys Res Commun, 322, 1111, 10.1016/j.bbrc.2004.07.096 Kislinger, 2001, RAGE mediates inflammation and enhanced expression of tissue factor in the vasculature of diabetic apolipoprotein E null mice, Arterioscler Thromb Vasc Biol, 21, 905, 10.1161/01.ATV.21.6.905 Wendt, 2003, RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy, Am J Pathol, 162, 1123, 10.1016/S0002-9440(10)63909-0 Jackson, 2011, Update on the aldehyde dehydrogenase gene (ALDH) superfamily, Hum Genomics, 5, 283, 10.1186/1479-7364-5-4-283 Wang, 2009, Substrate specificity of human and yeast aldehyde dehydrogenases, Chem Biol Interact, 178, 36, 10.1016/j.cbi.2008.10.002 Yoshida, 1994, Genetic polymorphisms of alcohol metabolizing enzymes related to alcohol sensitivity and alcoholic diseases, Alcohol Alcohol, 29, 693 Ducci, 2008, Genetic approaches to addiction: genes and alcohol, Addiction, 103, 1414, 10.1111/j.1360-0443.2008.02203.x Kanda, 2009, Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese, Cancer Sci, 100, 296, 10.1111/j.1349-7006.2008.01044.x